HighTower Advisors’s Immutep IMMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-540
Closed -$18.9K – 3805
2025
Q3
$18.9K Buy
540
+140
+35% +$4.75K ﹤0.01% 3677
2025
Q2
$13.1K Buy
+400
New +$13.9K ﹤0.01% 3630
2024
Q4
– Sell
-360
Closed -$16K – 3934
2024
Q3
$16K Buy
+360
New +$15.9K ﹤0.01% 3532
2023
Q4
– Sell
-600
Closed -$23K – 3734
2023
Q3
$23K Buy
+600
New +$24.4K ﹤0.01% 3315
2023
Q1
– Sell
-500
Closed -$18K – 3541
2022
Q4
$18K Buy
+500
New +$19.8K ﹤0.01% 3137
2021
Q4
– Sell
-1,000
Closed -$77K – 3380
2021
Q3
$77K Buy
1,000
+200
+25% +$14.9K ﹤0.01% 2879
2021
Q2
$62K Sell
800
-1,300
-62% -$103K ﹤0.01% 2868
2021
Q1
$129K Buy
2,100
+295
+16% +$18K ﹤0.01% 2712
2020
Q4
$114K Buy
+1,805
New +$79.6K ﹤0.01% 2322

Other funds holding IMMP

HighTower Advisors's IMMP Position: Q4 2025 in Review

HighTower Advisors sold out of Immutep (IMMP) in Q4 2025, closing a stake of 540 shares — an estimated $18.9K sold.

HighTower Advisors first reported a position in IMMP in Q4 2020 and held it in 9 quarters. The position peaked at $129K in Q1 2021. 24 funds tracked by Wall St. Rank hold IMMP as of Q4 2025.

  • HighTower Advisors reported no remaining Immutep position as of Q4 2025 after selling out during the quarter.
  • HighTower Advisors sold 540 Immutep shares in Q4 2025, an estimated $18.9K.
  • HighTower Advisors first reported a position in Immutep in Q4 2020 and held it in 9 quarters.
  • HighTower Advisors's Immutep position peaked at $129K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Immutep as of Q4 2025.

Based on HighTower Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.